v3.26.1
HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]        
Accumulated deficit $ 18,756,503   $ 17,858,617  
Liabilities 2,672,914   $ 2,323,652  
Gross proceeds $ 200,000 $ 86,000    
Common Stock [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Number of shares sold 88,889   232,444  
Sale of stock, price per share $ 2.25   $ 2.25 $ 2.25
Gross proceeds $ 200,000   $ 523,000  
Stock subscribed     $ 125,000  
Sanovas Ophthalmology LLC [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Due to related party $ 966,000